Australia
# |
Name |
EBIT Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
69.51%
|
June 30, 2024 | USD 157.25 | 0.24% |
|
Australia |
|
2 |
62.52%
|
June 30, 2024 | USD 7.32 | 6.16% |
|
Australia |
|
3 |
25.83%
|
June 30, 2024 | USD 173.13 | 0.11% |
|
Australia |
|
4 |
8.01%
|
June 30, 2024 | USD 21.11 | 1.40% |
|
Australia |
|
5 |
5.98%
|
June 30, 2024 | USD 2.14 | 0.82% |
|
Australia |
|
6 |
3.54%
|
June 30, 2024 | USD 20.43 | 1.47% |
|
Australia |
|
7 |
3.27%
|
Dec. 31, 2023 | USD 15.47 | 4.25% |
|
Australia |
|
8 |
2.36%
|
June 30, 2024 | USD 1.33 | 6.17% |
|
Australia |
|
9 |
0.75%
|
Jan. 31, 2024 | USD 1.81 | -0.44% |
|
Australia |
|
10 |
-14.64%
|
Dec. 31, 2023 | USD 1.27 | -1.68% |
|
Australia |
|
11 |
-17.14%
|
June 30, 2024 | USD 0.62 | -2.68% |
|
Australia |
|
12 |
-47.76%
|
June 30, 2024 | USD 2.80 | 2.04% |
|
Australia |
|
13 |
-141.33%
|
June 30, 2024 | USD 2.00 | 1.52% |
|
Australia |
|
14 |
-177.64%
|
June 30, 2024 | USD 0.74 | -1.40% |
|
Australia |
|
15 |
-389.35%
|
June 30, 2024 | USD 2.37 | 1.84% |
|
Australia |
|
16 |
-490.61%
|
June 30, 2024 | USD 3.31 | -4.06% |
|
Australia |
|
17 |
-982.24%
|
June 30, 2024 | USD 1.58 | -2.06% |
|
Australia |
|
18 |
-1,211.84%
|
June 30, 2024 | USD 1.93 | -0.52% |
|
Australia |
|
19 |
-1,240.68%
|
June 30, 2024 | USD 1.53 | 1.32% |
|
Australia |
|
20 |
-1,695.28%
|
Dec. 31, 2023 | USD 5.88 | 0.14% |
|
Australia |
|
21 |
-155,058.33%
|
June 30, 2024 | USD 1.77 | -1.67% |
|
Australia |
|
22 |
-160,526.36%
|
June 30, 2024 | USD 3.82 | 6.70% |
|
Australia |
The Pharmaceuticals company in Australia with the highest EBIT Margin is Pro Medicus Limited (ASX: PME.AX) at 69.51%.
The Pharmaceuticals company in Australia with the lowest EBIT Margin is Opthea Limited (NasdaqGS: OPT) at -160,526.36%.
The top 10 Pharmaceuticals companies in Australia by EBIT Margin are Pro Medicus Limited, Clinuvel Pharmaceuticals Limited, CSL Limited, Ansell Limited, Australian Clinical Labs Limited, EBOS Group Limited, Telix Pharmaceuticals Limited, PolyNovo Limited, Sigma Healthcare Limited and Cyclopharm Limited.
The bottom 10 Pharmaceuticals companies in Australia by EBIT Margin are Opthea Limited, Incannex Healthcare Limited, Anteris Technologies Ltd, Kazia Therapeutics Limited, Immutep Limited, Mesoblast Limited, Alterity Therapeutics Limited, Clarity Pharmaceuticals Ltd, PYC Therapeutics Limited and Immuron Limited.